Cargando…

SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study

BACKGROUND: Immunocompromised people (ICP) and elderly individuals (older than 80 years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions that may include a reduction of social contacts and participation in acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dopfer-Jablonka, Alexandra, Steffens, Sandra, Müller, Frank, Mikuteit, Marie, Niewolik, Jacqueline, Cossmann, Anne, Stankov, Metodi V., Behrens, Georg M. N., Hummers, Eva, Heesen, Gloria, Schröder, Dominik, Roder, Sascha, Klawonn, Frank, Vahldiek, Kai, Hasenkamp, Justin, Kallusky, Jonathan, Falk, Christine S., Overbeck, Tobias R., Heinemann, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035970/ https://www.ncbi.nlm.nih.gov/pubmed/35468758 http://dx.doi.org/10.1186/s12879-022-07347-w

Ejemplares similares

Social participation during the COVID-19 pandemic in persons with a high risk for a severe course of COVID-19 – results of a longitudinal, multi-center observational study in Germany
por: Schröder, Dominik, et al.
Publicado: (2023)

The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons – Results of a Multicenter Observational Study
por: Heesen, Gloria, et al.
Publicado: (2022)

Feasibility of self-organized blood sample collection in adults for study purposes in a primary care setting
por: Schröder, Dominik, et al.
Publicado: (2023)

Social participation and mental health of immunocompromised individuals before and after COVID-19 vaccination–Results of a longitudinal observational study over three time points
por: Heesen, Gloria, et al.
Publicado: (2022)

Development and Validation of a Questionnaire to Assess Social Participation of High Risk-Adults in Germany During the COVID-19 Pandemic
por: Schröder, Dominik, et al.
Publicado: (2022)

Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
por: Niewolik, Jacqueline, et al.
Publicado: (2022)

Long-term Consequences of COVID-19 and the Pandemic: Protocol for a Web-Based, Longitudinal Observational Study (DEFEAT)
por: Mikuteit, Marie, et al.
Publicado: (2022)

Self-reported Tinnitus and Vertigo or Dizziness in a Cohort of Adult Long COVID Patients
por: Degen, Chantal Vanessa, et al.
Publicado: (2022)

Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial
por: Schröder, Dominik, et al.
Publicado: (2022)

Impfeinstellung, Erwartungen und Impferfahrung von Immunsupprimierten bei COVID-19-Impfungen: Ergebnisse einer Längsschnittstudie
por: Müller, Frank, et al.
Publicado: (2022)

Soziale Teilhabe und Hautkrebs während der COVID-19-Pandemie
por: Niewolik, Jacqueline, et al.
Publicado: (2023)

Audiological profile of adult Long COVID patients
por: Degen, C.V., et al.
Publicado: (2022)

Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals
por: Behrens, Georg M. N., et al.
Publicado: (2020)

Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
por: Behrens, Georg M. N., et al.
Publicado: (2020)

Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
por: Jedicke, Nils, et al.
Publicado: (2021)

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
por: Nehlmeier, Inga, et al.
Publicado: (2023)

Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of long COVID and ex COVID human subjects
por: Mikuteit, Marie, et al.
Publicado: (2023)

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
por: Gussarow, Daniel, et al.
Publicado: (2021)

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
por: Dulovic, Alex, et al.
Publicado: (2022)

Effects of Pre-Existing Mental Conditions on Fatigue and Psychological Symptoms Post-COVID-19
por: Homann, Stefanie, et al.
Publicado: (2022)

How do immunocompromised people experience the changes in their working lives during the COVID-19 pandemic? Results from a mixed-methods study in Germany
por: Wegener, Greta S., et al.
Publicado: (2023)

SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
por: Behrens, Georg MN, et al.
Publicado: (2021)

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
por: Barros-Martins, Joana, et al.
Publicado: (2021)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
por: Arora, Prerna, et al.
Publicado: (2023)

Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
por: Hoffmann, Markus, et al.
Publicado: (2023)

Migrant healthcare workers during COVID-19: bringing an intersectional health system-related approach into pandemic protection. A German case study
por: Kuhlmann, Ellen, et al.
Publicado: (2023)

The risk management of contingent convertible (CoCo) bonds
por: De Spiegeleer, Jan, et al.
Publicado: (2018)

Health workers’ perception vs medically approved COVID-19 infection risk: the risk communication gap: Ellen Kuhlmann
por: Kuhlmann, E, et al.
Publicado: (2022)

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
por: Becker, Matthias, et al.
Publicado: (2022)

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
por: Behrens, Georg M. N., et al.
Publicado: (2022)

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
por: Arora, Prerna, et al.
Publicado: (2022)

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
por: Arora, Prerna, et al.
Publicado: (2022)

The Handbook of Hybrid Securities: Convertible Bonds, CoCo Bonds and Bail-In
por: Van Hulle, Cynthia
Publicado: (2014)

Healthcare Workers' Perceptions and Medically Approved COVID-19 Infection Risk: Understanding the Mental Health Dimension of the Pandemic. A German Hospital Case Study
por: Kuhlmann, Ellen, et al.
Publicado: (2022)

SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
por: Arora, Prerna, et al.
Publicado: (2022)

Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
por: Sidarovich, Anzhalika, et al.
Publicado: (2022)

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
por: Arora, Prerna, et al.
Publicado: (2021)

Leakages in District Heating Networks—Model-Based Data Set Quality Assessment and Localization
por: Vahldiek, Kai, et al.
Publicado: (2022)

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern
por: Odak, Ivan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ooagnuior74ljqt5p6sqmsg61m